This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Eyegene Inc.. Active years: 2015-2020.
Company Filing History:
Years Active: 2015-2020
Title: Innovations by Soo-Mee Kwon
Introduction
Soo-Mee Kwon is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical treatments, particularly in addressing vascular-related diseases. With a total of 2 patents, Kwon's work showcases his dedication to advancing healthcare solutions.
Latest Patents
Kwon's latest patents focus on methods for treating vascular-related diseases. One of his patents describes a method that includes administering a peptide with the sequence Xaa-Gly-Asp to subjects in need. This peptide may have sequences of SEQ ID NOS: 1, 2, 4, 6 to 10. The targeted vascular-related diseases include edema and ischemia, which can result from blood leakage, damage to blood vessels, or abnormal angiogenesis.
Career Highlights
Soo-Mee Kwon is currently associated with Eyegene Inc., where he continues to innovate in the medical field. His work is characterized by a commitment to developing effective treatments for complex health issues.
Collaborations
Kwon collaborates with talented individuals such as Doo-Sik Kim and Yang-Je Cho, contributing to a dynamic research environment that fosters innovation.
Conclusion
Soo-Mee Kwon's contributions to medical science through his patents and collaborations highlight his role as a key innovator in the treatment of vascular-related diseases. His work continues to pave the way for advancements in healthcare solutions.